Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements. | Front Immunol | 2022 | 36091031 | PubTator, text mining | PubMed |
| Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradation. | Mol Ther Oncolytics | 2022 | 36090478 | PubTator, text mining | PubMed |
| Endocrine therapy resistance: what we know and future directions. | Explor Target Antitumor Ther | 2022 | 36071983 | PubTator, text mining | PubMed |
| Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression. | J Exp Med | 2022 | 36066491 | PubTator, text mining | PubMed |
| Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia. | Heliyon | 2022 | 36061025 | PubTator, text mining | PubMed |
| Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases. | Curr Neuropharmacol | 2022 | 36043794 | PubTator, text mining | PubMed |
| 3D chromatin remodeling potentiates transcriptional programs driving cell invasion. | Proc Natl Acad Sci U S A | 2022 | 36037342 | PubTator, text mining | PubMed |
| Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death. | Adv Sci (Weinh) | 2022 | 36031387 | PubTator, text mining | PubMed |
| Overview of Research into mTOR Inhibitors. | Molecules | 2022 | 36014530 | PubTator, text mining | PubMed |
| Design, Synthesis and Mechanistic Studies of Novel Isatin-Pyrazole Hydrazone Conjugates as Selective and Potent Bacterial MetAP Inhibitors. | Antibiotics (Basel) | 2022 | 36009995 | PubTator, text mining | PubMed |
| PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC). | Biomedicines | 2022 | 36009440 | PubTator, text mining | PubMed |
| Androgen-Induced MIG6 Regulates Phosphorylation of Retinoblastoma Protein and AKT to Counteract Non-Genomic AR Signaling in Prostate Cancer Cells. | Biomolecules | 2022 | 36008945 | PubTator, text mining | PubMed |
| CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responses. | Front Immunol | 2022 | 35990699 | PubTator, text mining | PubMed |
| PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120. | EBioMedicine | 2022 | 35985167 | PubTator, text mining | PubMed |
| Carbon source availability drives nutrient utilization in CD8+ T cells. | Cell Metab | 2022 | 35981545 | PubTator, text mining | PubMed |
| GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post-allo-HSCT. | Blood | 2022 | 35981475 | PubTator, text mining | PubMed |
| Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation. | J Hematol Oncol | 2022 | 35978321 | PubTator, text mining | PubMed |
| Insulin increases placental triglyceride as a potential mechanism for fetal adiposity in maternal obesity. | Mol Metab | 2022 | 35970449 | PubTator, text mining | PubMed |
| PEBP4 Directs the Malignant Behavior of Hepatocellular Carcinoma Cells via Regulating mTORC1 and mTORC2. | Int J Mol Sci | 2022 | 35955931 | PubTator, text mining | PubMed |
| Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via mTORC1/S6K Signaling Pathway. | Int J Mol Sci | 2022 | 35955892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=19